Foresight invests additional GBP1.5m in portfolio company Biotherapy Services
Listed private equity and infrastructure investment manager Foresight Group, has made a GBP1.5 million follow-on investment in portfolio company Biotherapy Services Ltd (BTS), a pharmaceutical biotech company. The funds will be used to support the clinical development of RAPIDTM Biodynamic Haematogel, currently in phase 2b/3 clinical trials in the treatment